Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5

Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Osteoprotegerin (OPG), known to regulate bone mass by inhibiting osteoclast differentiation and activation, might also play a role in vascular calcification. Increased circulating OPG levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Marques, Gustavo Lenci, Hayashi, Shirley, Bjällmark, Anna, Larsson, Matilda, Riella, Miguel, Olandoski, Marcia, Lindholm, Bengt, Nascimento, Marcelo Mazza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844415/
https://www.ncbi.nlm.nih.gov/pubmed/33510348
http://dx.doi.org/10.1038/s41598-021-82072-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7844415/
https://www.ncbi.nlm.nih.gov/pubmed/33510348
http://dx.doi.org/10.1038/s41598-021-82072-z

Ejemplares similares